Pregnancy decreases rat CYP1A2 activity and expression

Drug Metabolism and Disposition

Volumn 39, Issue 1, 2011, Pages 4-7

  Walker, Alysa A ^a   Leslie, Dickmann ^a,b   Isoherranen, Nina ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A2; ESTRADIOL; MESSENGER RNA; PROGESTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEMETHYLATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HORMONAL REGULATION; LIVER CELL; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

ANIMALS; CYTOCHROME P-450 CYP1A2; ESTRADIOL; ESTROGENS; FEMALE; HEPATOCYTES; HUMANS; LIVER; MICROSOMES, LIVER; MODELS, ANIMAL; PREGNANCY; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

RATTUS;

EID: 78650736861     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.110.035766     Document Type: Article

References (15)

1. Abdi F, Pollard I, and Wilkinson J (1993) Placental transfer and foetal disposition of caffeine and its immediate metabolites in the 20-day pregnant rat: function of dose. Xenobiotica 23:449-456.
2. Anderson GD (2005) Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 44:989-1008.
3. Carter BL, Driscoll CE, and Smith GD (1986) Theophylline clearance during pregnancy. Obstet Gynecol 68:555-559.
4. Czekaj P, Wiaderkiewicz A, Florek E, and Wiaderkiewicz R (2005) Tobacco smoke-dependent changes in cytochrome P450 1A1, 1A2, and 2E1 protein expressions in fetuses, newborns, pregnant rats, and human placenta. Arch Toxicol 79:13-24.
5. Dickmann LJ, Tay S, Senn TD, Zhang H, Visone A, Unadkat JD, Hebert MF, and Isoherranen N (2008) Changes in maternal liver Cyp2c and Cyp2d expression and activity during rat pregnancy. Biochem Pharmacol 75:1677-1687.
6. Eugster HP, Probst M, Würgler FE, and Sengstag C (1993) Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae.Drug Metab Dispos 21:43-49.
7. Kivela A (1991) Serum melatonin during human pregnancy. Acta Endocrinol (Copenh) 124: 233-237.
8. Karjalainen MJ, Neuvonen PJ, and Backman JT (2008) In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions. Basic Clin Pharmacol Toxicol 103:157-165.
9. Laine K, Palovaara S, Tapanainen P, and Manninen P (1999) Plasma tacrine concentrations are significantly increased by concomitant hormone replacement therapy. Clin Pharmacol Ther 66:602-608.
10. Mathias AA, Maggio-Price L, Lai Y, Gupta A, and Unadkat JD (2006) Changes in pharmacokinetics of anti-HIV protease inhibitors during pregnancy: the role of CYP3A and Pglycoprotein. J Pharmacol Exp Ther 316:1202-1209.
11. Relling MV, Lin JS, Ayers GD, and Evans WE (1992) Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clin Pharmacol Ther 52:643-658.
12. Rettie AE, Eddy AC, Heimark LD, Gibaldi M, and Trager WF (1989) Characteristics of warfarin hydroxylation catalyzed by human liver microsomes. Drug Metab Dispos 17:265-270.
13. Tracy TS, Venkataramanan R, Glover DD, Caritis SN, and National Institute for Child Health and Human Development Network of Maternal-Fetal-Medicine Units (2005) Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy. Am J Obstet Gynecol 192:633-639.
14. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, and Speleman R (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034.
15. Zhang H, Wu X, Wang H, Mikheev AM, Mao Q, and Unadkat JD (2008) Effect of pregnancy on cytochrome P450 3a and P-glycoprotein expression and activity in the mouse: mechanisms, tissue specificity, and time course. Mol Pharmacol 74:714-723.